REGENXBIO (RGNX) Stock Insights

RGNX price $7.04 +0.45 +6.74%

Ticker
RGNX
Price
$7.04
Change
+0.45 +6.74%
Market cap ?
$465.06M
P/E ?
-1.89
Forward P/E ?
10.59
Dividend yield ?
0.00%
Beta ?
0.93
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
458900010393000218505000352330001545670004703470001127240009024200083328000170441000

REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an…

Fair value

RGNX fair value $18.57. Price $7.04. Price is 62% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 71.27M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.43% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 66.01M. Net debt 226.05M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare RGNX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-1.30—14.88M
2026-08-060.430.08108.02M97.63M
2026-05-14-1.72-1.366.39M25.84M
2026-03-05-1.30-1.0130.34M43.96M
2025-11-06-1.20-1.3829.73M59.26M
2025-08-07-1.38-1.1321.36M110.02M
2025-05-120.120.4189.01M105.35M
2025-03-13-1.01-1.2721.21M23.70M
2024-11-06-1.17-1.1624.20M23.45M
2024-08-01-1.05-1.2922.30M24.33M
2024-05-08-1.38-1.2815.62M23.52M
2024-02-27-1.43-1.2722.21M34.00M
2023-11-08-1.41-1.4428.91M36.09M
2023-08-02-1.66-1.2619.98M34.50M
2023-05-03-1.53-1.5219.14M30.60M
2023-02-28-1.38-1.4831.34M37.45M
2022-11-03-1.75-1.5526.51M30.81M
2022-08-03-1.58-1.4432.65M28.31M
2022-05-04-1.62-1.2922.22M27.22M
2022-03-016.674.71398.65M427.83M
2021-11-02-1.37-0.8730.77M31.49M
2021-08-09-1.36-1.0822.04M29.02M
2021-05-05-1.20-1.1318.88M23.23M
2021-03-01-1.241.1121.45M61.50M
2020-11-040.23-0.8998.91M284.13M
2020-08-06-0.91-0.8916.57M16.20M
2020-05-07-1.08-0.8717.64M14.21M
2020-02-26-0.72-0.4011.77M7.19M
2019-11-05-0.94-0.9114.70M11.10M
2019-08-07-0.72-0.507.88M120.19M
2019-05-07-0.89-0.85884.00K854.20K
2019-02-270.04-0.3240.78M126.04M
2018-11-07-0.56-0.865.31M4.17M
2018-08-080.151.9040.03M164.13M
2018-05-083.041.00132.39M43.55M
2018-03-06-0.51-0.712.04M3.28M
2017-11-08-0.67-0.711.34M1.44M
2017-08-08-0.47-0.816.56M10.47M
2017-05-09-0.82-0.77455.00K421.71K
2017-03-07-0.74-0.601.70M1.72M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-01Malzahn CraigSell234$9.322.18K
2026-09-01Chan MitchellSell4.90K$9.3245.69K
2026-08-27Ciongoli Gregory AustinBuy53.41K$9.36499.68K
2026-08-26Ciongoli Gregory AustinBuy49.20K$9.14449.71K
2026-08-25Ciongoli Gregory AustinBuy69.61K$8.91620.22K
2026-08-25Ciongoli Gregory AustinBuy15.43K——
2026-08-25Ciongoli Gregory AustinOther0——
2026-08-01PAKOLA STEVESell7.47K$9.6972.36K
2026-08-01Christmas Patrick J.Sell4.70K$9.6945.53K
2026-07-02PAKOLA STEVEBuy2.16K$7.8616.99K
2026-07-02PAKOLA STEVESell2.16K$13.6429.48K
2026-07-02PAKOLA STEVESell2.16K$7.8616.99K
2026-07-01Simpson CurranSell6.82K$13.0989.25K
2026-07-01PAKOLA STEVEBuy36.73K$7.86288.66K
2026-07-01PAKOLA STEVESell36.73K$12.86472.28K
2026-07-01PAKOLA STEVESell36.73K$7.86288.66K
2026-06-30Simpson CurranBuy1.45K$10.1814.79K
2026-06-29PAKOLA STEVESell19.61K$11.04216.47K
2026-05-29Tasse DanielBuy46.60K$7.01326.67K
2026-05-29Tasse DanielBuy9.81K——
2026-05-29STUMP DAVID CBuy46.60K$7.01326.67K
2026-05-29STUMP DAVID CBuy9.81K——
2026-05-29Zachary JenniferBuy46.60K$7.01326.67K
2026-05-29Zachary JenniferBuy9.81K——
2026-05-29Mills Kenneth T.Buy9.81K——
2026-05-29Mills Kenneth T.Buy46.60K$7.01326.67K
2026-05-29MIGAUSKY GEORGE VBuy46.60K$7.01326.67K
2026-05-29MIGAUSKY GEORGE VBuy9.81K——
2026-05-29KARABELAS ARGERIS NBuy46.60K$7.01326.67K
2026-05-29KARABELAS ARGERIS NBuy9.81K——
2026-05-29Glucksmann AlexandraBuy46.60K$7.01326.67K
2026-05-29Glucksmann AlexandraBuy9.81K——
2026-05-29Fox Allan M.Buy46.60K$7.01326.67K
2026-05-29Fox Allan M.Buy9.81K——
2026-05-29Bennett JeanBuy46.60K$7.01326.67K
2026-05-29Bennett JeanBuy9.81K——
2026-05-11PAKOLA STEVESell15.31K$11.02168.71K
2026-03-10PAKOLA STEVESell5.12K$10.3553.03K
2026-02-01Christmas Patrick J.Sell4.70K$11.1652.45K
2026-02-01PAKOLA STEVESell5.27K$11.1658.78K
2026-01-27Mills Kenneth T.Buy225.00K$13.092.95M
2026-01-27Mills Kenneth T.Sell221.75K$13.412.97M
2026-01-27Mills Kenneth T.Sell225.00K$13.092.95M
2026-01-06PAKOLA STEVEBuy65.85K——
2026-01-06PAKOLA STEVEBuy35.40K$14.18502.00K
2026-01-06Malzahn CraigBuy65.85K——
2026-01-06Malzahn CraigBuy35.40K$14.18502.00K
2026-01-06Simpson CurranBuy144.86K——
2026-01-06Simpson CurranBuy233.65K$14.183.31M
2026-01-06Christmas Patrick J.Buy73.75K——
2026-01-06Christmas Patrick J.Buy39.65K$14.18562.24K
2026-01-06Chan MitchellBuy73.75K——
2026-01-06Chan MitchellBuy39.65K$14.18562.24K
2026-01-02Simpson CurranSell18.56K$14.40267.25K
2026-01-02Malzahn CraigSell1.24K$14.4017.83K
2026-01-02Christmas Patrick J.Sell9.79K$14.40141.02K
2026-01-02PAKOLA STEVESell18.25K$14.40262.76K
2025-12-31Simpson CurranBuy951$7.006.65K
2025-10-09Simpson CurranSell20.81K$12.62262.63K
2025-09-29Simpson CurranSell7.62K$10.0376.47K
2025-09-10Simpson CurranSell7.73K$10.0277.49K
2025-09-01Malzahn CraigSell234$8.932.09K
2025-09-01Chan MitchellSell4.90K$8.9343.77K
2025-08-01Christmas Patrick J.Sell4.70K$8.1938.48K
2025-07-01Simpson CurranSell4.70K$8.2338.69K
2025-05-30Fox Allan M.Buy39.81K$8.85352.36K
2025-05-30Fox Allan M.Buy7.77K——
2025-05-30Zachary JenniferBuy39.81K$8.85352.36K
2025-05-30Zachary JenniferBuy7.77K——
2025-05-30Tasse DanielBuy39.81K$8.85352.36K
2025-05-30Tasse DanielBuy7.77K——
2025-05-30STUMP DAVID CBuy39.81K$8.85352.36K
2025-05-30STUMP DAVID CBuy7.77K——
2025-05-30Mills Kenneth T.Buy7.77K——
2025-05-30Mills Kenneth T.Buy39.81K$8.85352.36K
2025-05-30MIGAUSKY GEORGE VBuy39.81K$8.85352.36K
2025-05-30MIGAUSKY GEORGE VBuy7.77K——
2025-05-30Glucksmann AlexandraBuy39.81K$8.85352.36K
2025-05-30Glucksmann AlexandraBuy7.77K——
2025-05-30KARABELAS ARGERIS NBuy39.81K$8.85352.36K
2025-05-30KARABELAS ARGERIS NBuy7.77K——
2025-05-30Bennett JeanBuy39.81K$8.85352.36K
2025-05-30Bennett JeanBuy7.77K——
2025-05-12Mills Kenneth T.Buy20.60K$3.7677.46K
2025-05-12Mills Kenneth T.Sell20.60K$7.91163.05K
2025-05-12Mills Kenneth T.Sell20.60K$3.7677.46K
2025-03-27Mills Kenneth T.Buy30.75K$3.76115.63K
2025-03-27Mills Kenneth T.Sell30.75K$3.76115.63K
2025-03-13Malzahn CraigOther0——
2025-03-13Malzahn CraigOther19.13K$22.25425.64K
2025-03-13Malzahn CraigOther12.75K$18.34233.84K
2025-03-13Malzahn CraigOther31.20K$40.681.27M
2025-03-13Malzahn CraigOther9.60K$44.97431.71K
2025-03-13Malzahn CraigOther9.60K$34.31329.38K
2025-03-13Malzahn CraigOther33.15K$7.86260.56K
2025-02-01Christmas Patrick J.Sell4.70K$8.0737.93K
2025-02-01PAKOLA STEVESell5.26K$8.0742.47K
2025-02-01Danos OlivierSell5.45K$8.0744.00K
2025-01-02Simpson CurranBuy478.61K$7.863.76M
2025-01-02PAKOLA STEVEBuy64.29K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 177, holders -12 vs prior quarter. Ownership 81.23%.

HolderSharesChangeChange %Value
BLACKROCK, INC.6.40M614.63K+10.63%76.64M
REDMILE GROUP, LLC4.37M00.00%52.34M
STATE STREET CORP2.97M239.69K+8.78%35.59M
JPMORGAN CHASE & CO2.21M-1.27M-36.44%26.19M
VANGUARD CAPITAL MANAGEMENT LLC2.11M100.41K+5.00%25.25M
MORGAN STANLEY1.95M-112.92K-5.47%23.40M
GOLDMAN SACHS GROUP INC1.42M-418.01K-22.72%17.03M
AQR CAPITAL MANAGEMENT LLC1.38M326.65K+31.06%16.51M
VANGUARD PORTFOLIO MANAGEMENT LLC1.36M336.65K+33.04%16.24M
MARSHALL WACE, LLP1.28M1.28MNew15.39M
GEODE CAPITAL MANAGEMENT, LLC1.24M103.80K+9.13%14.87M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC800.00K-700.00K-46.67%9.58M
NUVEEN, LLC740.03K158.01K+27.15%8.87M
DIMENSIONAL FUND ADVISORS LP731.59K-278.80K-27.59%8.76M
D. E. SHAW & CO., INC.712.81K426.81K+149.23%8.54M
TWO SIGMA INVESTMENTS, LP669.81K114.92K+20.71%8.02M
CITADEL ADVISORS LLC669.02K669.02KNew8.01M
STIFEL FINANCIAL CORP560.73K167.96K+42.76%6.72M
BANK OF AMERICA CORP /DE/518.54K193.69K+59.62%6.21M
22NW, LP492.76K00.00%5.90M
MILLENNIUM MANAGEMENT LLC480.76K195.59K+68.59%5.76M
PALE FIRE CAPITAL SE466.21K-27.52K-5.57%5.59M
NORTHERN TRUST CORP421.84K28.20K+7.16%5.05M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.396.45K396.45KNew4.75M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC396.45K5.85K+1.50%4.75M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

REGENXBIO (RGNX) Stock Insights

RGNX$7.04+0.45 +6.74%

$465.06M

Market Cap

-1.89

P/E

10.59

Forward P/E

—

Score

Price History